PT  - JOURNAL ARTICLE
AU  - Reza, Symon
AU  - Kovarovic, Brandon
AU  - Bluestein, Danny
TI  - Assessing Post-TAVR Cardiac Conduction Abnormalities Risk Using a Digital Twin of a Beating Heart
AID  - 10.1101/2024.03.28.24305028
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.28.24305028
4099  - http://medrxiv.org/content/early/2024/03/29/2024.03.28.24305028.short
4100  - http://medrxiv.org/content/early/2024/03/29/2024.03.28.24305028.full
AB  - Transcatheter aortic valve replacement (TAVR) has rapidly displaced surgical aortic valve replacement (SAVR). However, certain post-TAVR complications persist, with cardiac conduction abnormalities (CCA) being one of the major ones. The elevated pressure exerted by the TAVR stent onto the conduction fibers situated between the aortic annulus and the His bundle, in proximity to the atrioventricular (AV) node, may disrupt the cardiac conduction leading to the emergence of CCA. In his study, an in-silico framework was developed to assess the CCA risk, incorporating the effect of a dynamic beating heart and pre-procedural parameters such as implantation depth and preexisting cardiac asynchrony in the new onset of post-TAVR CCA. A self-expandable TAVR device deployment was simulated inside an electro-mechanically coupled beating heart model in five patient scenarios, including three implantation depths, and two preexisting cardiac asynchronies: (i) a right bundle branch block (RBBB) and (ii) a left bundle branch block (LBBB). Subsequently, several biomechanical parameters were analyzed to assess the post-TAVR CCA risk. The results manifested a lower cumulative contact pressure on the conduction fibers following TAVR for aortic deployment (0.018 MPa) compared to baseline (0.29 MPa) and ventricular deployment (0.52 MPa). Notably, the preexisting RBBB demonstrated a higher cumulative contact pressure (0.34 MPa) compared to the baseline and preexisting LBBB (0.25 MPa). Deeper implantation and preexisting RBBB cause higher stresses and contact pressure on the conduction fibers leading to an increased risk of post-TAVR CCA. Conversely, implantation above the MS landmark and preexisting LBBB reduces the risk.Competing Interest StatementAuthor D.B. has an equity interest in Polynova Cardiovascular Inc. Author B.K. is a consultant for Polynova Cardiovascular Inc. The other authors declare that they have no competing interests.Funding StatementThis project is funded by NIH-NIBIB BRP U01EB026414 (DB)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data is available within the body of the manuscript and the supplemental dataTAVRTranscatheter aortic valve replacementCCACardiac conduction abnormalityMSMembranous septumPPIPermanent pacemaker implantationA-VAtrioventricularAOIArea of interestHBHis bundleCPIContact pressure indexCTAComputed tomography angiographyLBBBLeft bundle branch blockRBBBRight bundle branch blockRCLRight coronary leafletNCLNon-coronary leafletLCLLeft coronary leaflet